20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10894 | CSF1R-IN-1 | c-Fms | |
CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM. | |||
T13194 | CSF1R-IN-2 | c-Fms , c-Met/HGFR , Src | |
CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively). | |||
T64066 | CSF1R-IN-3 | c-Fms , CSF-1R | |
CSF1R-IN-3 is an orally effective CSF-1R inhibitor with an IC50 value of 2.1 nM. CSF1R-IN-3 has anti-proliferative activity against colorectal cancer cells. CSF1R-IN-3 exhibits anti-tumour effects and immune enhancing ef... | |||
T62557 | CSF1R-IN-14 | ||
CSF1R-IN-14, an isoindolinone derivative compound, is a potent inhibitor of CSF1R. CSF1R-IN-14 has potential for cancer disease research. | |||
T79472 | CSF1R-IN-17 | c-Fms | |
CSF1R-IN-17 (compound 9) is a potent, selective antagonist of CSF1R, exhibiting an inhibition concentration half-maximum (IC50) of 0.2 nM. It is capable of inhibiting osteoclast differentiation [1]. | |||
T62342 | CSF1R-IN-4 | ||
CSF1R-IN-4 is a potent inhibitor of CSF-1R. CSF1R-IN-4 can affect the exchange of inflammatory factors between TAM and glioma cells. CSF1R-IN-4 has potential for the study of cancer diseases. EGFR-IN-40. | |||
T62187 | CSF1R-IN-6 | ||
CSF1R-IN-6 is a potent inhibitor of CSF1R. CSF1R-IN-6 is a potent inhibitor of CSF1R, which is expressed in macrophages and is dependent on the CSF-1/CSF-1R signalling pathway for survival and differentiation of macropha... | |||
T62364 | CSF1R-IN-5 | ||
CSF1R-IN-5 is a potent inhibitor of CSF1R. CSF1R-IN-5 can affect the exchange of inflammatory factors between TAM and glioma cells. CSF1R-IN-5 has the potential to be used in the study of cancer diseases. | |||
T62190 | CSF1R-IN-7 | ||
CSF1R-IN-7 (Formula I) is a CSF-1R inhibitor that can be used to study Alzheimer's disease. | |||
T61893 | CSF1R-IN-12 | ||
CSF1R-IN-12 is an effective CSF1R inhibitor. CSF1R-IN-12 has research potential in cancer diseases. | |||
T61554 | CSF1R-IN-13 | ||
CSF1R-IN-13 is a powerful CSF1R inhibitor with potential applications in researching cancer diseases [1]. CSF1R, also known as colony stimulating factor 1 receptor, is a critical growth factor that regulates various cell... | |||
T62318 | CSF1R-IN-9 | ||
CSF1R-IN-9 (Compound 46) is a CSF-1R inhibitor (IC50: 0.028 μM). | |||
T62313 | CSF1R-IN-10 | ||
CSF1R-IN-10 (Compound 48) is a CSF-1R inhibitor (IC50: 0.005 μM). | |||
T62390 | CSF1R-IN-8 | ||
CSF1R-IN-8 (Compound 22) is a CSF-1R inhibitor (IC50: 0.012 μM). | |||
T72574 | Axl/Mer/CSF1R-IN-1 | ||
Axl/Mer-IN-1 is a compound that functions as an inhibitor for Axl/Mer receptor tyrosine kinase (Axl/Mer RTK) and CSF1R, exhibiting dissociation constants (Kds) of less than 0.1 μM. | |||
T5586 | CFMS Receptor Inhibitor II | c-Fms | |
cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor | |||
T14380 | AZD7507 | CSF-1R , HER , Sodium Channel | |
AZD7507 is a CSF-1R inhibitor with an IC50 of 32 nM. AZD7507 has antitumor activity. | |||
T6119 | Sotuletinib | BLZ945 | c-Fms , CSF-1R |
Sotuletinib (BLZ945) is an orally active, effective and specific CSF-1R inhibitor (IC50: 1 nM), >1000-fold selective against its closest receptor tyrosine kinase homologs. | |||
T10652 | Vimseltinib | DCC-3014 | c-Fms , CSF-1R , c-Kit |
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM). | |||
TQ0015 | PRN1371 | c-Fms , FGFR , CSF-1R | |
PRN1371 is a specific and potent FGFR1-4 and CSF1R inhibitor (IC50s: 0.6/1.3/4.1/19.3/8.1 nM for FGFR1/2/3/4 and CSF1R). |